Novel motif:29: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ |
Latest revision as of 14:39, 9 September 2013
name: | motif29_TAGCTCGGCT |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0033599 | regulation of mammary gland epithelial cell proliferation | 6.965793e-9 |
GO:0072178 | nephric duct morphogenesis | 1.425000e-8 |
GO:0010999 | regulation of eIF2 alpha phosphorylation by heme | 2.003127e-8 |
GO:0009589 | detection of UV | 2.003127e-8 |
GO:0061072 | iris morphogenesis | 2.358703e-8 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 3.103485e-8 |
GO:0030382 | sperm mitochondrion organization | 5.057791e-8 |
GO:0021796 | cerebral cortex regionalization | 6.387521e-8 |
GO:0072179 | nephric duct formation | 7.539077e-8 |
GO:0072176 | nephric duct development | 8.114107e-8 |
GO:0048102 | autophagic cell death | 1.409492e-7 |
GO:0021903 | rostrocaudal neural tube patterning | 1.722329e-7 |
GO:0021532 | neural tube patterning | 1.795481e-7 |
GO:0021568 | rhombomere 2 development | 3.379139e-7 |
GO:0071353 | cellular response to interleukin-4 | 4.520706e-7 |
GO:0003184 | pulmonary valve morphogenesis | 4.879386e-7 |
GO:0021555 | midbrain-hindbrain boundary morphogenesis | 8.923760e-7 |
GO:0006335 | DNA replication-dependent nucleosome assembly | 9.134301e-7 |
GO:2000667 | positive regulation of interleukin-13 secretion | 1.285958e-6 |
GO:2000703 | negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation | 1.285958e-6 |
GO:2000665 | regulation of interleukin-13 secretion | 1.285958e-6 |
GO:2000734 | negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation | 1.285958e-6 |
GO:2000664 | positive regulation of interleukin-5 secretion | 1.285958e-6 |
GO:2000607 | negative regulation of cell proliferation involved in mesonephros development | 1.285958e-6 |
GO:2000662 | regulation of interleukin-5 secretion | 1.285958e-6 |
GO:0021993 | initiation of neural tube closure | 1.559048e-6 |
GO:0032312 | regulation of ARF GTPase activity | 1.874758e-6 |
GO:0006171 | cAMP biosynthetic process | 2.248430e-6 |
GO:0007501 | mesodermal cell fate specification | 2.322888e-6 |
GO:0008054 | cyclin catabolic process | 2.410355e-6 |
GO:0030917 | midbrain-hindbrain boundary development | 2.608449e-6 |
GO:0006189 | 'de novo' IMP biosynthetic process | 3.181918e-6 |
GO:0006474 | N-terminal protein amino acid acetylation | 3.460321e-6 |
GO:0048846 | axon extension involved in axon guidance | 4.881690e-6 |
GO:0009107 | lipoate biosynthetic process | 5.170918e-6 |
GO:0018277 | protein deamination | 6.150732e-6 |
GO:0021517 | ventral spinal cord development | 8.113527e-6 |
GO:0021658 | rhombomere 3 morphogenesis | 8.164126e-6 |
GO:0031365 | N-terminal protein amino acid modification | 8.761593e-6 |
GO:0016480 | negative regulation of transcription from RNA polymerase III promoter | 1.051420e-5 |
GO:0070670 | response to interleukin-4 | 1.079263e-5 |
GO:0035414 | negative regulation of catenin import into nucleus | 1.191376e-5 |
GO:0051935 | glutamate uptake involved in synaptic transmission | 1.214468e-5 |
GO:0060678 | dichotomous subdivision of terminal units involved in ureteric bud branching | 1.281939e-5 |
GO:0070544 | histone H3-K36 demethylation | 1.305019e-5 |
GO:0046501 | protoporphyrinogen IX metabolic process | 1.368950e-5 |
GO:0021523 | somatic motor neuron differentiation | 1.380025e-5 |
GO:0033522 | histone H2A ubiquitination | 1.422604e-5 |
GO:0072676 | lymphocyte migration | 1.904020e-5 |
GO:0006268 | DNA unwinding involved in replication | 2.370167e-5 |
GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific | 2.868248e-5 |
GO:0021915 | neural tube development | 2.921923e-5 |
GO:0045906 | negative regulation of vasoconstriction | 3.882832e-5 |
GO:0001710 | mesodermal cell fate commitment | 3.918735e-5 |
GO:0042421 | norepinephrine biosynthetic process | 4.588069e-5 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 4.715997e-5 |
GO:0070845 | polyubiquitinated misfolded protein transport | 4.715997e-5 |
GO:0006361 | transcription initiation from RNA polymerase I promoter | 4.775433e-5 |
GO:0010836 | negative regulation of protein ADP-ribosylation | 4.820698e-5 |
GO:0003180 | aortic valve morphogenesis | 5.287854e-5 |
GO:0048755 | branching morphogenesis of a nerve | 5.373055e-5 |
GO:0003002 | regionalization | 6.158056e-5 |
GO:2000597 | positive regulation of optic nerve formation | 6.516643e-5 |
GO:0061360 | optic chiasma development | 6.516643e-5 |
GO:0021633 | optic nerve structural organization | 6.516643e-5 |
GO:0021650 | vestibulocochlear nerve formation | 6.516643e-5 |
GO:0035799 | ureter maturation | 6.516643e-5 |
GO:0006353 | transcription termination, DNA-dependent | 6.899058e-5 |
GO:0010896 | regulation of triglyceride catabolic process | 6.912846e-5 |
GO:2000611 | positive regulation of thyroid hormone generation | 7.012031e-5 |
GO:0061290 | canonical Wnt receptor signaling pathway involved in metanephric kidney development | 7.201876e-5 |
GO:0050747 | positive regulation of lipoprotein metabolic process | 7.354728e-5 |
GO:0005993 | trehalose catabolic process | 7.354728e-5 |
GO:0050935 | iridophore differentiation | 7.354842e-5 |
GO:0048937 | lateral line nerve glial cell development | 7.354842e-5 |
GO:0002769 | natural killer cell inhibitory signaling pathway | 7.636611e-5 |
GO:0061143 | alveolar primary septum development | 7.840893e-5 |
GO:0097039 | protein linear polyubiquitination | 7.978407e-5 |
GO:0006892 | post-Golgi vesicle-mediated transport | 8.193364e-5 |
GO:0006363 | termination of RNA polymerase I transcription | 9.020383e-5 |
GO:0051567 | histone H3-K9 methylation | 9.733769e-5 |
GO:0032006 | regulation of TOR signaling cascade | 9.992288e-5 |
GO:0060035 | notochord cell development | 1.070762e-4 |
GO:0031104 | dendrite regeneration | 1.070762e-4 |
GO:0009190 | cyclic nucleotide biosynthetic process | 1.074521e-4 |
GO:0060670 | branching involved in embryonic placenta morphogenesis | 1.117551e-4 |
GO:0009106 | lipoate metabolic process | 1.119741e-4 |
GO:0001675 | acrosome assembly | 1.213420e-4 |
GO:0060669 | embryonic placenta morphogenesis | 1.464646e-4 |
GO:0072107 | positive regulation of ureteric bud formation | 1.467370e-4 |
GO:0051006 | positive regulation of lipoprotein lipase activity | 1.615834e-4 |
GO:0001823 | mesonephros development | 1.830091e-4 |
GO:0090141 | positive regulation of mitochondrial fission | 1.890825e-4 |
GO:0021877 | forebrain neuron fate commitment | 1.923813e-4 |
GO:0051058 | negative regulation of small GTPase mediated signal transduction | 1.955335e-4 |
GO:0035518 | histone H2A monoubiquitination | 1.977924e-4 |
GO:0046058 | cAMP metabolic process | 2.025203e-4 |
GO:0034723 | DNA replication-dependent nucleosome organization | 2.057784e-4 |
GO:0070988 | demethylation | 2.147338e-4 |
GO:0043048 | dolichyl monophosphate biosynthetic process | 2.187576e-4 |
GO:0035104 | positive regulation of transcription via sterol regulatory element binding | 2.363679e-4 |
GO:0021554 | optic nerve development | 2.489792e-4 |
GO:0046676 | negative regulation of insulin secretion | 2.579392e-4 |
GO:0046580 | negative regulation of Ras protein signal transduction | 2.701938e-4 |
GO:0000414 | regulation of histone H3-K36 methylation | 2.760259e-4 |
GO:0070145 | mitochondrial asparaginyl-tRNA aminoacylation | 2.764705e-4 |
GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c | 2.851082e-4 |
GO:0010988 | regulation of low-density lipoprotein particle clearance | 2.851082e-4 |
GO:0021930 | cerebellar granule cell precursor proliferation | 3.245797e-4 |
GO:0045943 | positive regulation of transcription from RNA polymerase I promoter | 3.501662e-4 |
GO:0032392 | DNA geometric change | 3.603666e-4 |
GO:0006756 | AMP phosphorylation | 3.701259e-4 |
GO:0051041 | positive regulation of calcium-independent cell-cell adhesion | 3.740223e-4 |
GO:0050902 | leukocyte adhesive activation | 3.740223e-4 |
GO:0010991 | negative regulation of SMAD protein complex assembly | 3.740223e-4 |
GO:0031290 | retinal ganglion cell axon guidance | 3.755114e-4 |
GO:0010897 | negative regulation of triglyceride catabolic process | 3.929928e-4 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 3.929928e-4 |
GO:0003175 | tricuspid valve development | 3.929928e-4 |
GO:0048240 | sperm capacitation | 4.189464e-4 |
GO:0043501 | skeletal muscle adaptation | 4.232707e-4 |
GO:0090278 | negative regulation of peptide hormone secretion | 4.322646e-4 |
GO:0006701 | progesterone biosynthetic process | 4.424514e-4 |
GO:0060430 | lung saccule development | 4.500882e-4 |
GO:0060037 | pharyngeal system development | 4.542887e-4 |
GO:0050957 | equilibrioception | 4.661992e-4 |
GO:0016576 | histone dephosphorylation | 4.716343e-4 |
GO:0006032 | chitin catabolic process | 4.757802e-4 |
GO:0042752 | regulation of circadian rhythm | 4.921045e-4 |
GO:0009187 | cyclic nucleotide metabolic process | 4.957449e-4 |
GO:0034442 | regulation of lipoprotein oxidation | 5.141163e-4 |
GO:0006188 | IMP biosynthetic process | 5.141163e-4 |
GO:0009231 | riboflavin biosynthetic process | 5.237161e-4 |
GO:0090129 | positive regulation of synapse maturation | 5.660302e-4 |
GO:0010002 | cardioblast differentiation | 5.891504e-4 |
GO:0051901 | positive regulation of mitochondrial depolarization | 5.995179e-4 |
GO:0035721 | intraflagellar retrograde transport | 6.198550e-4 |
GO:0048733 | sebaceous gland development | 6.405243e-4 |
GO:2000178 | negative regulation of neural precursor cell proliferation | 6.618008e-4 |
GO:0018076 | N-terminal peptidyl-lysine acetylation | 6.744946e-4 |
GO:0034198 | cellular response to amino acid starvation | 6.968350e-4 |
GO:0048793 | pronephros development | 7.026235e-4 |
GO:0035329 | hippo signaling cascade | 7.585533e-4 |
GO:0006298 | mismatch repair | 7.585533e-4 |
GO:0006983 | ER overload response | 7.901555e-4 |
GO:0032508 | DNA duplex unwinding | 7.949691e-4 |
GO:0045764 | positive regulation of cellular amino acid metabolic process | 8.718973e-4 |
GO:0021522 | spinal cord motor neuron differentiation | 8.771670e-4 |
GO:0048880 | sensory system development | 9.042452e-4 |
GO:0022417 | protein maturation by protein folding | 9.214522e-4 |
GO:0090140 | regulation of mitochondrial fission | 9.226989e-4 |
GO:0021678 | third ventricle development | 9.321075e-4 |
GO:0045007 | depurination | 9.459300e-4 |
GO:0035646 | endosome to melanosome transport | 9.576455e-4 |
GO:0048246 | macrophage chemotaxis | 9.876335e-4 |
GO:0090102 | cochlea development | 1.010136e-3 |
GO:0034378 | chylomicron assembly | 1.017976e-3 |
GO:0016598 | protein arginylation | 1.017976e-3 |
GO:0043503 | skeletal muscle fiber adaptation | 1.056572e-3 |
GO:0021798 | forebrain dorsal/ventral pattern formation | 1.095392e-3 |
GO:0006308 | DNA catabolic process | 1.115284e-3 |
GO:0006360 | transcription from RNA polymerase I promoter | 1.158917e-3 |
GO:0021905 | forebrain-midbrain boundary formation | 1.175529e-3 |
GO:0021918 | regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment | 1.175529e-3 |
GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain | 1.175529e-3 |
GO:0014028 | notochord formation | 1.175529e-3 |
GO:0003322 | pancreatic A cell development | 1.175529e-3 |
GO:0050689 | negative regulation of defense response to virus by host | 1.186649e-3 |
GO:0090232 | positive regulation of spindle checkpoint | 1.188561e-3 |
GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing | 1.202214e-3 |
GO:0006552 | leucine catabolic process | 1.225058e-3 |
GO:0031929 | TOR signaling cascade | 1.229674e-3 |
GO:0048675 | axon extension | 1.250150e-3 |
GO:0019532 | oxalate transport | 1.293609e-3 |
GO:0043491 | protein kinase B signaling cascade | 1.330116e-3 |
GO:0033088 | negative regulation of immature T cell proliferation in thymus | 1.398765e-3 |
GO:0060060 | post-embryonic retina morphogenesis in camera-type eye | 1.401587e-3 |
GO:0070541 | response to platinum ion | 1.437356e-3 |
GO:0032008 | positive regulation of TOR signaling cascade | 1.445786e-3 |
GO:0048178 | negative regulation of hepatocyte growth factor biosynthetic process | 1.461389e-3 |
GO:0048561 | establishment of organ orientation | 1.461389e-3 |
GO:0042727 | flavin-containing compound biosynthetic process | 1.461389e-3 |
GO:0042335 | cuticle development | 1.461389e-3 |
GO:0034635 | glutathione transport | 1.461389e-3 |
GO:0060620 | regulation of cholesterol import | 1.478815e-3 |
GO:0042218 | 1-aminocyclopropane-1-carboxylate biosynthetic process | 1.478815e-3 |
GO:0021546 | rhombomere development | 1.493898e-3 |
GO:0090128 | regulation of synapse maturation | 1.494102e-3 |
GO:0009952 | anterior/posterior pattern specification | 1.512681e-3 |
GO:0072221 | metanephric distal convoluted tubule development | 1.535150e-3 |
GO:0030573 | bile acid catabolic process | 1.624038e-3 |
GO:0003406 | retinal pigment epithelium development | 1.624038e-3 |
GO:0042297 | vocal learning | 1.645125e-3 |
GO:0032012 | regulation of ARF protein signal transduction | 1.686965e-3 |
GO:0003279 | cardiac septum development | 1.804294e-3 |
GO:0000266 | mitochondrial fission | 1.826299e-3 |
GO:0021520 | spinal cord motor neuron cell fate specification | 1.932324e-3 |
GO:0060577 | pulmonary vein morphogenesis | 1.990912e-3 |
GO:0035922 | foramen ovale closure | 1.990912e-3 |
GO:0003193 | pulmonary valve formation | 1.990912e-3 |
GO:0072003 | kidney rudiment formation | 2.036596e-3 |
GO:0006281 | DNA repair | 2.058852e-3 |
GO:0006476 | protein deacetylation | 2.061333e-3 |
GO:0002792 | negative regulation of peptide secretion | 2.061342e-3 |
GO:0007161 | calcium-independent cell-matrix adhesion | 2.065977e-3 |
GO:0032205 | negative regulation of telomere maintenance | 2.074510e-3 |
GO:0061156 | pulmonary artery morphogenesis | 2.076144e-3 |
GO:0048627 | myoblast development | 2.076144e-3 |
GO:0030046 | parallel actin filament bundle assembly | 2.151998e-3 |
GO:0060947 | cardiac vascular smooth muscle cell differentiation | 2.153138e-3 |
GO:0035566 | regulation of metanephros size | 2.205206e-3 |
GO:0035601 | protein deacylation | 2.279386e-3 |
GO:0009155 | purine deoxyribonucleotide catabolic process | 2.344956e-3 |
GO:0050690 | regulation of defense response to virus by virus | 2.352148e-3 |
GO:0048247 | lymphocyte chemotaxis | 2.382455e-3 |
GO:0071887 | leukocyte apoptosis | 2.421655e-3 |
GO:0070076 | histone lysine demethylation | 2.452723e-3 |
GO:2000683 | regulation of cellular response to X-ray | 2.513210e-3 |
GO:0060127 | prolactin secreting cell differentiation | 2.638082e-3 |
GO:0061325 | cell proliferation involved in outflow tract morphogenesis | 2.638082e-3 |
GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis | 2.638082e-3 |
GO:2000774 | positive regulation of cellular senescence | 2.679587e-3 |
GO:0035986 | senescence-associated heterochromatin focus formation | 2.679587e-3 |
GO:0032808 | lacrimal gland development | 2.681202e-3 |
GO:0060158 | activation of phospholipase C activity by dopamine receptor signaling pathway | 2.837270e-3 |
GO:0071233 | cellular response to leucine | 2.849103e-3 |
GO:0072300 | positive regulation of metanephric glomerulus development | 2.887682e-3 |
GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 2.946711e-3 |
GO:0050746 | regulation of lipoprotein metabolic process | 2.948802e-3 |
GO:0045358 | negative regulation of interferon-beta biosynthetic process | 2.968451e-3 |
GO:0006551 | leucine metabolic process | 3.138370e-3 |
GO:0021631 | optic nerve morphogenesis | 3.153975e-3 |
GO:0030513 | positive regulation of BMP signaling pathway | 3.181458e-3 |
GO:0006903 | vesicle targeting | 3.258432e-3 |
GO:0030302 | deoxynucleotide transport | 3.419463e-3 |
GO:0002017 | regulation of blood volume by renal aldosterone | 3.419463e-3 |
GO:0003105 | negative regulation of glomerular filtration | 3.419463e-3 |
GO:0007208 | activation of phospholipase C activity by serotonin receptor signaling pathway | 3.428348e-3 |
GO:0033598 | mammary gland epithelial cell proliferation | 3.479906e-3 |
GO:0006421 | asparaginyl-tRNA aminoacylation | 3.561356e-3 |
GO:0070198 | protein localization to chromosome, telomeric region | 3.701738e-3 |
GO:0007004 | telomere maintenance via telomerase | 3.701738e-3 |
GO:0072182 | regulation of nephron tubule epithelial cell differentiation | 3.702491e-3 |
GO:0021562 | vestibulocochlear nerve development | 3.741417e-3 |
GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis | 3.766184e-3 |
GO:0033119 | negative regulation of RNA splicing | 3.801343e-3 |
GO:0060075 | regulation of resting membrane potential | 3.879273e-3 |
GO:0048320 | axial mesoderm formation | 3.900868e-3 |
GO:0042073 | intraflagellar transport | 3.927315e-3 |
GO:0019064 | viral envelope fusion with host membrane | 3.927315e-3 |
GO:0046498 | S-adenosylhomocysteine metabolic process | 3.950229e-3 |
GO:0018364 | peptidyl-glutamine methylation | 4.006258e-3 |
GO:0034447 | very-low-density lipoprotein particle clearance | 4.011170e-3 |
GO:0072170 | metanephric tubule development | 4.125477e-3 |
GO:2000594 | positive regulation of metanephric DCT cell differentiation | 4.128383e-3 |
GO:0039003 | pronephric field specification | 4.128383e-3 |
GO:0072305 | negative regulation of mesenchymal stem cell apoptosis involved in metanephric nephron morphogenesis | 4.128383e-3 |
GO:0060711 | labyrinthine layer development | 4.142030e-3 |
GO:0001946 | lymphangiogenesis | 4.149207e-3 |
GO:0035886 | vascular smooth muscle cell differentiation | 4.194661e-3 |
GO:0090104 | pancreatic E cell differentiation | 4.219620e-3 |
GO:0032439 | endosome localization | 4.219620e-3 |
GO:0003311 | pancreatic D cell differentiation | 4.219620e-3 |
GO:0051488 | activation of anaphase-promoting complex activity | 4.318296e-3 |
GO:0035284 | brain segmentation | 4.318296e-3 |
GO:0060850 | regulation of transcription involved in cell fate commitment | 4.349653e-3 |
GO:0014056 | regulation of acetylcholine secretion | 4.409845e-3 |
GO:0045113 | regulation of integrin biosynthetic process | 4.427146e-3 |
GO:0090197 | positive regulation of chemokine secretion | 4.516048e-3 |
GO:0003148 | outflow tract septum morphogenesis | 4.568116e-3 |
GO:0006359 | regulation of transcription from RNA polymerase III promoter | 4.722730e-3 |
GO:0021978 | telencephalon regionalization | 4.760098e-3 |
GO:0072289 | metanephric nephron tubule formation | 4.774343e-3 |
GO:2000378 | negative regulation of reactive oxygen species metabolic process | 4.781489e-3 |
GO:0046836 | glycolipid transport | 4.836830e-3 |
GO:0051572 | negative regulation of histone H3-K4 methylation | 4.878114e-3 |
GO:0072040 | negative regulation of mesenchymal stem cell apoptosis involved in nephron morphogenesis | 4.959518e-3 |
GO:0015728 | mevalonate transport | 4.965257e-3 |
GO:2000691 | negative regulation of cardiac muscle cell myoblast differentiation | 4.965257e-3 |
GO:0034259 | negative regulation of Rho GTPase activity | 5.036482e-3 |
GO:0032912 | negative regulation of transforming growth factor beta2 production | 5.036482e-3 |
GO:0035024 | negative regulation of Rho protein signal transduction | 5.104939e-3 |
GO:0032674 | regulation of interleukin-5 production | 5.109866e-3 |
GO:0006098 | pentose-phosphate shunt | 5.185282e-3 |
GO:0021510 | spinal cord development | 5.186586e-3 |
GO:0016569 | covalent chromatin modification | 5.187816e-3 |
GO:0016570 | histone modification | 5.205518e-3 |
GO:0000415 | negative regulation of histone H3-K36 methylation | 5.224078e-3 |
GO:0033326 | cerebrospinal fluid secretion | 5.224078e-3 |
GO:0033590 | response to cobalamin | 5.307122e-3 |
GO:0021893 | cerebral cortex GABAergic interneuron fate commitment | 5.307122e-3 |
GO:0006117 | acetaldehyde metabolic process | 5.307122e-3 |
GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment | 5.307122e-3 |
GO:0050881 | musculoskeletal movement | 5.430599e-3 |
GO:0051355 | proprioception involved in equilibrioception | 5.537423e-3 |
GO:0046940 | nucleoside monophosphate phosphorylation | 5.537423e-3 |
GO:0046500 | S-adenosylmethionine metabolic process | 5.775541e-3 |
GO:0000738 | DNA catabolic process, exonucleolytic | 5.775541e-3 |
GO:0072202 | cell differentiation involved in metanephros development | 5.825614e-3 |
GO:0045750 | positive regulation of S phase of mitotic cell cycle | 5.883598e-3 |
GO:0003056 | regulation of vascular smooth muscle contraction | 5.883598e-3 |
GO:0072017 | distal tubule development | 5.917909e-3 |
GO:0061205 | paramesonephric duct development | 6.062320e-3 |
GO:0045218 | zonula adherens maintenance | 6.321910e-3 |
GO:0010633 | negative regulation of epithelial cell migration | 6.321910e-3 |
GO:0072234 | metanephric nephron tubule development | 6.411571e-3 |
GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus | 6.454537e-3 |
GO:0001830 | trophectodermal cell fate commitment | 6.516444e-3 |
GO:0043586 | tongue development | 6.545371e-3 |
GO:0048193 | Golgi vesicle transport | 6.612707e-3 |
GO:0021879 | forebrain neuron differentiation | 6.655478e-3 |
GO:0097045 | phosphatidylserine exposure on blood platelet | 6.781219e-3 |
GO:0032418 | lysosome localization | 6.794755e-3 |
GO:0006362 | transcription elongation from RNA polymerase I promoter | 6.810932e-3 |
GO:0048593 | camera-type eye morphogenesis | 6.867407e-3 |
GO:0042726 | flavin-containing compound metabolic process | 7.001895e-3 |
GO:0090398 | cellular senescence | 7.069662e-3 |
GO:0014020 | primary neural tube formation | 7.205029e-3 |
GO:0090103 | cochlea morphogenesis | 7.208938e-3 |
GO:0042755 | eating behavior | 7.240783e-3 |
GO:0070071 | proton-transporting two-sector ATPase complex assembly | 7.483859e-3 |
GO:0060177 | regulation of angiotensin metabolic process | 7.558537e-3 |
GO:0071722 | detoxification of arsenic-containing substance | 7.761326e-3 |
GO:0072537 | fibroblast activation | 7.817025e-3 |
GO:0070989 | oxidative demethylation | 7.894291e-3 |
GO:0051318 | G1 phase | 8.031579e-3 |
GO:0021675 | nerve development | 8.042899e-3 |
GO:0032007 | negative regulation of TOR signaling cascade | 8.251931e-3 |
GO:0001833 | inner cell mass cell proliferation | 8.251931e-3 |
GO:0021904 | dorsal/ventral neural tube patterning | 8.444085e-3 |
GO:2000737 | negative regulation of stem cell differentiation | 8.464137e-3 |
GO:0034261 | negative regulation of Ras GTPase activity | 8.464137e-3 |
GO:0043249 | erythrocyte maturation | 8.483377e-3 |
GO:0032782 | bile acid secretion | 8.484597e-3 |
GO:0030327 | prenylated protein catabolic process | 8.484597e-3 |
GO:0006489 | dolichyl diphosphate biosynthetic process | 8.484597e-3 |
GO:0021666 | rhombomere 5 formation | 8.484597e-3 |
GO:0021660 | rhombomere 3 formation | 8.484597e-3 |
GO:0090224 | regulation of spindle organization | 8.549529e-3 |
GO:0003188 | heart valve formation | 8.549529e-3 |
GO:0051650 | establishment of vesicle localization | 8.596003e-3 |
GO:0090234 | regulation of kinetochore assembly | 8.616726e-3 |
GO:0090169 | regulation of spindle assembly | 8.616726e-3 |
GO:0016574 | histone ubiquitination | 8.632381e-3 |
GO:0048280 | vesicle fusion with Golgi apparatus | 8.718777e-3 |
GO:0002200 | somatic diversification of immune receptors | 8.932066e-3 |
GO:0061364 | apoptosis involved in luteolysis | 9.010533e-3 |
GO:0016255 | attachment of GPI anchor to protein | 9.178191e-3 |
GO:0009301 | snRNA transcription | 9.190224e-3 |
GO:0001843 | neural tube closure | 9.299563e-3 |
GO:0003360 | brainstem development | 9.341978e-3 |
GO:0060457 | negative regulation of digestive system process | 9.412107e-3 |
GO:0042354 | L-fucose metabolic process | 9.423550e-3 |
GO:0016577 | histone demethylation | 9.438281e-3 |
GO:2001054 | negative regulation of mesenchymal cell apoptosis | 9.522505e-3 |
GO:0044339 | canonical Wnt receptor signaling pathway involved in osteoblast differentiation | 9.522505e-3 |
GO:0006481 | C-terminal protein methylation | 9.522505e-3 |
GO:0044338 | canonical Wnt receptor signaling pathway involved in mesenchymal stem cell differentiation | 9.522505e-3 |
GO:0021592 | fourth ventricle development | 9.524201e-3 |
GO:0010625 | positive regulation of Schwann cell proliferation | 9.587627e-3 |
GO:0060455 | negative regulation of gastric acid secretion | 9.620183e-3 |
GO:0046814 | virion attachment, binding of host cell surface coreceptor | 9.620183e-3 |
GO:0048239 | negative regulation of DNA recombination at telomere | 9.620183e-3 |
GO:0065001 | specification of axis polarity | 9.850663e-3 |
GO:0032042 | mitochondrial DNA metabolic process | 9.850663e-3 |
GO:0033151 | V(D)J recombination | 9.976987e-3 |
GO:0007029 | endoplasmic reticulum organization | 1.002534e-2 |
GO:0042772 | DNA damage response, signal transduction resulting in transcription | 1.027108e-2 |
GO:0001977 | renal system process involved in regulation of blood volume | 1.031537e-2 |
GO:0046717 | acid secretion | 1.034985e-2 |
GO:0000080 | G1 phase of mitotic cell cycle | 1.044201e-2 |
GO:0016056 | rhodopsin mediated signaling pathway | 1.050699e-2 |
GO:0060052 | neurofilament cytoskeleton organization | 1.061412e-2 |
GO:0006493 | protein O-linked glycosylation | 1.086222e-2 |
GO:0046092 | deoxycytidine metabolic process | 1.088720e-2 |
GO:0042376 | phylloquinone catabolic process | 1.088720e-2 |
GO:0061090 | positive regulation of sequestering of zinc ion | 1.088720e-2 |
GO:0071279 | cellular response to cobalt ion | 1.088720e-2 |
GO:0010637 | negative regulation of mitochondrial fusion | 1.088720e-2 |
GO:0000472 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.088720e-2 |
GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.088720e-2 |
GO:0034241 | positive regulation of macrophage fusion | 1.088720e-2 |
GO:0007099 | centriole replication | 1.099847e-2 |
GO:0070127 | tRNA aminoacylation for mitochondrial protein translation | 1.104174e-2 |
GO:0034260 | negative regulation of GTPase activity | 1.113137e-2 |
GO:0072282 | metanephric nephron tubule morphogenesis | 1.155427e-2 |
GO:0055089 | fatty acid homeostasis | 1.155826e-2 |
GO:0001820 | serotonin secretion | 1.157864e-2 |
GO:0045085 | negative regulation of interleukin-2 biosynthetic process | 1.157864e-2 |
GO:0006482 | protein demethylation | 1.173874e-2 |
GO:0000726 | non-recombinational repair | 1.176137e-2 |
GO:0002227 | innate immune response in mucosa | 1.180953e-2 |
GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly | 1.180953e-2 |
GO:0042355 | L-fucose catabolic process | 1.183325e-2 |
GO:0070231 | T cell apoptosis | 1.197621e-2 |
GO:0010310 | regulation of hydrogen peroxide metabolic process | 1.197981e-2 |
GO:0006026 | aminoglycan catabolic process | 1.218126e-2 |
GO:0006348 | chromatin silencing at telomere | 1.243818e-2 |
GO:0002765 | immune response-inhibiting signal transduction | 1.243818e-2 |
GO:0021515 | cell differentiation in spinal cord | 1.246599e-2 |
GO:0046724 | oxalic acid secretion | 1.246734e-2 |
GO:0035552 | oxidative single-stranded DNA demethylation | 1.246734e-2 |
GO:0019265 | glycine biosynthetic process, by transamination of glyoxylate | 1.246734e-2 |
GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle | 1.246734e-2 |
GO:0071888 | macrophage apoptosis | 1.266726e-2 |
GO:0034227 | tRNA thio-modification | 1.266726e-2 |
GO:0002098 | tRNA wobble uridine modification | 1.266726e-2 |
GO:0060621 | negative regulation of cholesterol import | 1.270821e-2 |
GO:0035993 | deltoid tuberosity development | 1.270821e-2 |
GO:0035425 | autocrine signaling | 1.291306e-2 |
GO:0010835 | regulation of protein ADP-ribosylation | 1.291306e-2 |
GO:0048702 | embryonic neurocranium morphogenesis | 1.296376e-2 |
GO:0060379 | cardiac muscle cell myoblast differentiation | 1.298660e-2 |
GO:0060520 | activation of prostate induction by androgen receptor signaling pathway | 1.298660e-2 |
GO:0045720 | negative regulation of integrin biosynthetic process | 1.298660e-2 |
GO:0019102 | male somatic sex determination | 1.298660e-2 |
GO:0002635 | negative regulation of germinal center formation | 1.298660e-2 |
GO:0060606 | tube closure | 1.308566e-2 |
GO:0090196 | regulation of chemokine secretion | 1.316403e-2 |
GO:0016575 | histone deacetylation | 1.334823e-2 |
GO:0006739 | NADP metabolic process | 1.343004e-2 |
GO:0051967 | negative regulation of synaptic transmission, glutamatergic | 1.346105e-2 |
GO:0070309 | lens fiber cell morphogenesis | 1.347515e-2 |
GO:0071615 | oxidative deethylation | 1.356807e-2 |
GO:0006742 | NADP catabolic process | 1.356807e-2 |
GO:0009403 | toxin biosynthetic process | 1.356807e-2 |
GO:0010898 | positive regulation of triglyceride catabolic process | 1.368845e-2 |
GO:0071529 | cementum mineralization | 1.381340e-2 |
GO:0001986 | negative regulation of the force of heart contraction involved in baroreceptor response to increased systemic arterial blood pressure | 1.381340e-2 |
GO:0006740 | NADPH regeneration | 1.409812e-2 |
GO:0090208 | positive regulation of triglyceride metabolic process | 1.424391e-2 |
GO:0022412 | cellular process involved in reproduction in multicellular organism | 1.437492e-2 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 1.451248e-2 |
GO:0051885 | positive regulation of anagen | 1.483300e-2 |
GO:2000824 | negative regulation of androgen receptor activity | 1.483300e-2 |
GO:0043381 | negative regulation of memory T cell differentiation | 1.483300e-2 |
GO:0008052 | sensory organ boundary specification | 1.483300e-2 |
GO:0014835 | myoblast cell differentiation involved in skeletal muscle regeneration | 1.483300e-2 |
GO:0042941 | D-alanine transport | 1.483300e-2 |
GO:0035564 | regulation of kidney size | 1.490948e-2 |
GO:0000416 | positive regulation of histone H3-K36 methylation | 1.496047e-2 |
GO:0003310 | pancreatic A cell differentiation | 1.513198e-2 |
GO:0006356 | regulation of transcription from RNA polymerase I promoter | 1.516980e-2 |
GO:0010822 | positive regulation of mitochondrion organization | 1.520505e-2 |
GO:0016446 | somatic hypermutation of immunoglobulin genes | 1.522847e-2 |
GO:0045918 | negative regulation of cytolysis | 1.525212e-2 |
GO:0051588 | regulation of neurotransmitter transport | 1.534227e-2 |
GO:0050434 | positive regulation of viral transcription | 1.538400e-2 |
GO:0051898 | negative regulation of protein kinase B signaling cascade | 1.544481e-2 |
GO:0060872 | semicircular canal development | 1.558716e-2 |
GO:0035573 | N-terminal peptidyl-serine trimethylation | 1.575119e-2 |
GO:0035572 | N-terminal peptidyl-serine dimethylation | 1.575119e-2 |
GO:0018016 | N-terminal peptidyl-proline dimethylation | 1.575119e-2 |
GO:0018012 | N-terminal peptidyl-alanine trimethylation | 1.575119e-2 |
GO:0008049 | male courtship behavior | 1.579819e-2 |
GO:0032981 | mitochondrial respiratory chain complex I assembly | 1.610037e-2 |
GO:0030433 | ER-associated protein catabolic process | 1.614537e-2 |
GO:0031444 | slow-twitch skeletal muscle fiber contraction | 1.624217e-2 |
GO:0045726 | positive regulation of integrin biosynthetic process | 1.624217e-2 |
GO:0006669 | sphinganine-1-phosphate biosynthetic process | 1.648133e-2 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 1.651908e-2 |
GO:0031936 | negative regulation of chromatin silencing | 1.675837e-2 |
GO:0043268 | positive regulation of potassium ion transport | 1.679550e-2 |
GO:0070593 | dendrite self-avoidance | 1.679550e-2 |
GO:0048025 | negative regulation of nuclear mRNA splicing, via spliceosome | 1.690280e-2 |
GO:0071333 | cellular response to glucose stimulus | 1.691460e-2 |
GO:0015734 | taurine transport | 1.697312e-2 |
GO:0043276 | anoikis | 1.697312e-2 |
GO:0006288 | base-excision repair, DNA ligation | 1.697367e-2 |
GO:0071625 | vocalization behavior | 1.709983e-2 |
GO:0032025 | response to cobalt ion | 1.714072e-2 |
GO:0030719 | P granule organization | 1.756101e-2 |
GO:0048484 | enteric nervous system development | 1.756592e-2 |
GO:0060837 | blood vessel endothelial cell differentiation | 1.757023e-2 |
GO:0045955 | negative regulation of calcium ion-dependent exocytosis | 1.771507e-2 |
GO:0048537 | mucosal-associated lymphoid tissue development | 1.779108e-2 |
GO:0001709 | cell fate determination | 1.782270e-2 |
GO:0006865 | amino acid transport | 1.788913e-2 |
GO:0061025 | membrane fusion | 1.807668e-2 |
GO:0014745 | negative regulation of muscle adaptation | 1.823614e-2 |
GO:0060676 | ureteric bud formation | 1.835131e-2 |
GO:0030718 | germ-line stem cell maintenance | 1.870310e-2 |
GO:0014807 | regulation of somitogenesis | 1.870310e-2 |
GO:0032461 | positive regulation of protein oligomerization | 1.887271e-2 |
GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification | 1.893201e-2 |
GO:0070171 | negative regulation of tooth mineralization | 1.914799e-2 |
GO:0048541 | Peyer's patch development | 1.922985e-2 |
GO:0046434 | organophosphate catabolic process | 1.941095e-2 |
GO:0001574 | ganglioside biosynthetic process | 1.973080e-2 |
GO:0006354 | transcription elongation, DNA-dependent | 1.975792e-2 |
GO:0006310 | DNA recombination | 1.993679e-2 |
GO:0014002 | astrocyte development | 2.009941e-2 |
GO:0021524 | visceral motor neuron differentiation | 2.033555e-2 |
GO:0009051 | pentose-phosphate shunt, oxidative branch | 2.033555e-2 |
GO:0021869 | forebrain ventricular zone progenitor cell division | 2.066933e-2 |
GO:0048708 | astrocyte differentiation | 2.087199e-2 |
GO:0021545 | cranial nerve development | 2.097079e-2 |
GO:0043923 | positive regulation by host of viral transcription | 2.100869e-2 |
GO:0045292 | nuclear mRNA cis splicing, via spliceosome | 2.117733e-2 |
GO:0006383 | transcription from RNA polymerase III promoter | 2.159003e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0031507 | heterochromatin formation | 4.936848e-12 |
GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation | 4.499433e-11 |
GO:0072074 | kidney mesenchyme development | 5.342260e-11 |
GO:2000774 | positive regulation of cellular senescence | 2.935777e-10 |
GO:0035986 | senescence-associated heterochromatin focus formation | 2.935777e-10 |
GO:0090402 | oncogene-induced senescence | 2.935777e-10 |
GO:0072124 | regulation of glomerular mesangial cell proliferation | 7.343170e-10 |
GO:0072215 | regulation of metanephros development | 1.199859e-9 |
GO:0072199 | regulation of mesenchymal cell proliferation involved in ureter development | 1.646229e-9 |
GO:0072015 | glomerular visceral epithelial cell development | 5.756320e-9 |
GO:0072166 | posterior mesonephric tubule development | 8.763862e-9 |
GO:0001823 | mesonephros development | 1.238752e-8 |
GO:0090183 | regulation of kidney development | 6.827051e-8 |
GO:0072107 | positive regulation of ureteric bud formation | 1.039701e-7 |
GO:0072075 | metanephric mesenchyme development | 1.518234e-7 |
GO:2000772 | regulation of cellular senescence | 2.142130e-7 |
GO:0072164 | mesonephric tubule development | 3.193407e-7 |
GO:0072012 | glomerulus vasculature development | 3.781926e-7 |
GO:0072189 | ureter development | 4.474442e-7 |
GO:0090192 | regulation of glomerulus development | 4.967215e-7 |
GO:0030202 | heparin metabolic process | 5.084882e-7 |
GO:0072112 | glomerular visceral epithelial cell differentiation | 6.050749e-7 |
GO:0003002 | regionalization | 6.642859e-7 |
GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development | 7.964511e-7 |
GO:0072125 | negative regulation of glomerular mesangial cell proliferation | 9.618988e-7 |
GO:0072298 | regulation of metanephric glomerulus development | 1.000171e-6 |
GO:0021877 | forebrain neuron fate commitment | 1.328294e-6 |
GO:2001076 | positive regulation of metanephric ureteric bud development | 1.361440e-6 |
GO:0007356 | thorax and anterior abdomen determination | 1.361440e-6 |
GO:0072302 | negative regulation of metanephric glomerular mesangial cell proliferation | 1.361440e-6 |
GO:0090343 | positive regulation of cell aging | 1.744142e-6 |
GO:0043045 | DNA methylation involved in embryo development | 1.800735e-6 |
GO:0031508 | centromeric heterochromatin formation | 2.377017e-6 |
GO:0008210 | estrogen metabolic process | 2.766560e-6 |
GO:0072193 | ureter smooth muscle cell differentiation | 2.815314e-6 |
GO:0072028 | nephron morphogenesis | 2.963767e-6 |
GO:0061302 | smooth muscle cell-matrix adhesion | 3.166041e-6 |
GO:0021893 | cerebral cortex GABAergic interneuron fate commitment | 3.405881e-6 |
GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment | 3.405881e-6 |
GO:0072098 | anterior/posterior pattern specification involved in kidney development | 3.503266e-6 |
GO:0048389 | intermediate mesoderm development | 3.503266e-6 |
GO:0046967 | cytosol to ER transport | 3.741900e-6 |
GO:0019060 | intracellular transport of viral proteins in host cell | 3.741900e-6 |
GO:0060911 | cardiac cell fate commitment | 3.907435e-6 |
GO:0042866 | pyruvate biosynthetic process | 5.490934e-6 |
GO:0001935 | endothelial cell proliferation | 5.957401e-6 |
GO:0072095 | regulation of branch elongation involved in ureteric bud branching | 6.036452e-6 |
GO:0060621 | negative regulation of cholesterol import | 6.462937e-6 |
GO:0051322 | anaphase | 7.622295e-6 |
GO:0090185 | negative regulation of kidney development | 8.813247e-6 |
GO:0048639 | positive regulation of developmental growth | 9.820792e-6 |
GO:0072303 | positive regulation of glomerular metanephric mesangial cell proliferation | 9.831686e-6 |
GO:0035269 | protein O-linked mannosylation | 9.831686e-6 |
GO:0090116 | C-5 methylation of cytosine | 1.010641e-5 |
GO:0018192 | enzyme active site formation via L-cysteine persulfide | 1.081907e-5 |
GO:0045299 | otolith mineralization | 1.081907e-5 |
GO:0033364 | mast cell secretory granule organization | 1.103370e-5 |
GO:0061004 | pattern specification involved in kidney development | 1.169789e-5 |
GO:0033373 | maintenance of protease location in mast cell secretory granule | 1.416738e-5 |
GO:0033382 | maintenance of granzyme B location in T cell secretory granule | 1.416738e-5 |
GO:0021532 | neural tube patterning | 1.444783e-5 |
GO:0007099 | centriole replication | 1.576627e-5 |
GO:0050710 | negative regulation of cytokine secretion | 1.582449e-5 |
GO:0072268 | pattern specification involved in metanephros development | 1.665385e-5 |
GO:0034377 | plasma lipoprotein particle assembly | 1.789221e-5 |
GO:0043252 | sodium-independent organic anion transport | 1.840992e-5 |
GO:0048484 | enteric nervous system development | 2.067657e-5 |
GO:0051451 | myoblast migration | 2.138196e-5 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 2.326008e-5 |
GO:0006777 | Mo-molybdopterin cofactor biosynthetic process | 2.661619e-5 |
GO:0021670 | lateral ventricle development | 2.669064e-5 |
GO:0060620 | regulation of cholesterol import | 2.862776e-5 |
GO:0061162 | establishment of monopolar cell polarity | 3.048563e-5 |
GO:0060612 | adipose tissue development | 3.167203e-5 |
GO:2000194 | regulation of female gonad development | 4.100961e-5 |
GO:0021978 | telencephalon regionalization | 4.365073e-5 |
GO:0003382 | epithelial cell morphogenesis | 4.584185e-5 |
GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling | 4.585136e-5 |
GO:0045064 | T-helper 2 cell differentiation | 5.027313e-5 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 5.041589e-5 |
GO:0010897 | negative regulation of triglyceride catabolic process | 5.041589e-5 |
GO:2000195 | negative regulation of female gonad development | 5.138584e-5 |
GO:0000090 | mitotic anaphase | 5.138584e-5 |
GO:0009108 | coenzyme biosynthetic process | 5.249810e-5 |
GO:0072111 | cell proliferation involved in kidney development | 5.370935e-5 |
GO:0021879 | forebrain neuron differentiation | 5.423301e-5 |
GO:0048745 | smooth muscle tissue development | 5.450664e-5 |
GO:0072006 | nephron development | 5.627678e-5 |
GO:0060192 | negative regulation of lipase activity | 5.659324e-5 |
GO:0090342 | regulation of cell aging | 5.886934e-5 |
GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain | 5.976886e-5 |
GO:0007224 | smoothened signaling pathway | 6.665159e-5 |
GO:0060675 | ureteric bud morphogenesis | 6.887078e-5 |
GO:0043558 | regulation of translational initiation in response to stress | 6.918208e-5 |
GO:0060231 | mesenchymal to epithelial transition | 7.341161e-5 |
GO:0051901 | positive regulation of mitochondrial depolarization | 7.895019e-5 |
GO:0047497 | mitochondrion transport along microtubule | 8.054504e-5 |
GO:0002740 | negative regulation of cytokine secretion involved in immune response | 8.911673e-5 |
GO:0060415 | muscle tissue morphogenesis | 9.017073e-5 |
GO:0001656 | metanephros development | 9.519608e-5 |
GO:0070508 | cholesterol import | 1.006903e-4 |
GO:2000683 | regulation of cellular response to X-ray | 1.061267e-4 |
GO:0071624 | positive regulation of granulocyte chemotaxis | 1.133074e-4 |
GO:0019348 | dolichol metabolic process | 1.135679e-4 |
GO:0022007 | convergent extension involved in neural plate elongation | 1.194797e-4 |
GO:0030210 | heparin biosynthetic process | 1.319904e-4 |
GO:0014051 | gamma-aminobutyric acid secretion | 1.391346e-4 |
GO:0001822 | kidney development | 1.470650e-4 |
GO:0031055 | chromatin remodeling at centromere | 1.478436e-4 |
GO:0021892 | cerebral cortex GABAergic interneuron differentiation | 1.514013e-4 |
GO:0048729 | tissue morphogenesis | 1.536949e-4 |
GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing | 1.537558e-4 |
GO:0072171 | mesonephric tubule morphogenesis | 1.557941e-4 |
GO:0006929 | substrate-dependent cell migration | 1.611854e-4 |
GO:0006656 | phosphatidylcholine biosynthetic process | 1.692745e-4 |
GO:0060923 | cardiac muscle cell fate commitment | 1.703030e-4 |
GO:0050709 | negative regulation of protein secretion | 1.738824e-4 |
GO:0090102 | cochlea development | 1.741703e-4 |
GO:0072126 | positive regulation of glomerular mesangial cell proliferation | 1.804844e-4 |
GO:0071506 | cellular response to mycophenolic acid | 1.804844e-4 |
GO:0048675 | axon extension | 2.023135e-4 |
GO:0035082 | axoneme assembly | 2.163191e-4 |
GO:0072073 | kidney epithelium development | 2.227342e-4 |
GO:0072284 | metanephric S-shaped body morphogenesis | 2.236207e-4 |
GO:0072278 | metanephric comma-shaped body morphogenesis | 2.236207e-4 |
GO:0071480 | cellular response to gamma radiation | 2.255452e-4 |
GO:0072190 | ureter urothelium development | 2.407186e-4 |
GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity | 2.438118e-4 |
GO:0032835 | glomerulus development | 2.443259e-4 |
GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint | 2.525922e-4 |
GO:0009798 | axis specification | 2.642901e-4 |
GO:0021871 | forebrain regionalization | 2.670895e-4 |
GO:0031128 | developmental induction | 2.704833e-4 |
GO:0072176 | nephric duct development | 2.763850e-4 |
GO:0070483 | detection of hypoxia | 2.838992e-4 |
GO:0035990 | tendon cell differentiation | 2.838992e-4 |
GO:0043921 | modulation by host of viral transcription | 2.857806e-4 |
GO:0072110 | glomerular mesangial cell proliferation | 2.862154e-4 |
GO:0001759 | organ induction | 2.870092e-4 |
GO:0002897 | positive regulation of central B cell tolerance induction | 2.877938e-4 |
GO:0002508 | central tolerance induction | 2.877938e-4 |
GO:0048715 | negative regulation of oligodendrocyte differentiation | 3.023998e-4 |
GO:0042036 | negative regulation of cytokine biosynthetic process | 3.137286e-4 |
GO:0006346 | methylation-dependent chromatin silencing | 3.219006e-4 |
GO:0009952 | anterior/posterior pattern specification | 3.285161e-4 |
GO:0032916 | positive regulation of transforming growth factor beta3 production | 3.305143e-4 |
GO:0019673 | GDP-mannose metabolic process | 3.305143e-4 |
GO:0032509 | endosome transport via multivesicular body sorting pathway | 3.424151e-4 |
GO:0090197 | positive regulation of chemokine secretion | 3.706054e-4 |
GO:0051573 | negative regulation of histone H3-K9 methylation | 3.706054e-4 |
GO:0010616 | negative regulation of cardiac muscle adaptation | 3.821112e-4 |
GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 3.821112e-4 |
GO:0034375 | high-density lipoprotein particle remodeling | 3.854329e-4 |
GO:0055008 | cardiac muscle tissue morphogenesis | 3.909030e-4 |
GO:0072172 | mesonephric tubule formation | 3.964524e-4 |
GO:0090103 | cochlea morphogenesis | 4.012330e-4 |
GO:0051642 | centrosome localization | 4.017406e-4 |
GO:0048644 | muscle organ morphogenesis | 4.032849e-4 |
GO:0072001 | renal system development | 4.110752e-4 |
GO:0035802 | adrenal cortex formation | 4.187019e-4 |
GO:0050713 | negative regulation of interleukin-1 beta secretion | 4.251155e-4 |
GO:0021678 | third ventricle development | 4.251155e-4 |
GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 4.285518e-4 |
GO:0051654 | establishment of mitochondrion localization | 4.316959e-4 |
GO:0033121 | regulation of purine nucleotide catabolic process | 4.333084e-4 |
GO:0072178 | nephric duct morphogenesis | 4.351259e-4 |
GO:0045168 | cell-cell signaling involved in cell fate commitment | 4.559311e-4 |
GO:0002098 | tRNA wobble uridine modification | 4.782385e-4 |
GO:0032481 | positive regulation of type I interferon production | 4.987671e-4 |
GO:0030325 | adrenal gland development | 5.035073e-4 |
GO:0010159 | specification of organ position | 5.042152e-4 |
GO:0044246 | regulation of multicellular organismal metabolic process | 5.129519e-4 |
GO:0072050 | S-shaped body morphogenesis | 5.165004e-4 |
GO:0072049 | comma-shaped body morphogenesis | 5.165004e-4 |
GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning | 5.359545e-4 |
GO:0072192 | ureter epithelial cell differentiation | 5.466426e-4 |
GO:0072198 | mesenchymal cell proliferation involved in ureter development | 5.466426e-4 |
GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development | 5.466426e-4 |
GO:0072101 | specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway | 5.466426e-4 |
GO:0072200 | negative regulation of mesenchymal cell proliferation involved in ureter development | 5.466426e-4 |
GO:2000007 | negative regulation of metanephric comma-shaped body morphogenesis | 5.466426e-4 |
GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis | 5.466426e-4 |
GO:0072097 | negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway | 5.466426e-4 |
GO:2000005 | negative regulation of metanephric S-shaped body morphogenesis | 5.466426e-4 |
GO:0090194 | negative regulation of glomerulus development | 5.466426e-4 |
GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis | 5.466426e-4 |
GO:0061151 | BMP signaling pathway involved in renal system segmentation | 5.466426e-4 |
GO:0071893 | BMP signaling pathway involved in nephric duct formation | 5.466426e-4 |
GO:0033590 | response to cobalamin | 5.466426e-4 |
GO:0007500 | mesodermal cell fate determination | 5.466426e-4 |
GO:0002635 | negative regulation of germinal center formation | 5.466426e-4 |
GO:0055020 | positive regulation of cardiac muscle fiber development | 5.466426e-4 |
GO:0048392 | intermediate mesodermal cell differentiation | 5.466426e-4 |
GO:0060502 | epithelial cell proliferation involved in lung morphogenesis | 5.466426e-4 |
GO:0061149 | BMP signaling pathway involved in ureter morphogenesis | 5.466426e-4 |
GO:0061155 | pulmonary artery endothelial tube morphogenesis | 5.466426e-4 |
GO:0060503 | bud dilation involved in lung branching | 5.466426e-4 |
GO:0043982 | histone H4-K8 acetylation | 5.479028e-4 |
GO:0043981 | histone H4-K5 acetylation | 5.479028e-4 |
GO:0006415 | translational termination | 5.615603e-4 |
GO:0048588 | developmental cell growth | 5.704316e-4 |
GO:0006941 | striated muscle contraction | 5.848165e-4 |
GO:0090398 | cellular senescence | 5.852118e-4 |
GO:0045090 | retroviral genome replication | 5.877946e-4 |
GO:0048227 | plasma membrane to endosome transport | 5.877946e-4 |
GO:0016078 | tRNA catabolic process | 5.877946e-4 |
GO:0001682 | tRNA 5'-leader removal | 5.877946e-4 |
GO:0052312 | modulation of transcription in other organism involved in symbiotic interaction | 5.898018e-4 |
GO:0009650 | UV protection | 6.014648e-4 |
GO:0007389 | pattern specification process | 6.054477e-4 |
GO:0001710 | mesodermal cell fate commitment | 6.467293e-4 |
GO:0060048 | cardiac muscle contraction | 6.516358e-4 |
GO:0048333 | mesodermal cell differentiation | 6.981136e-4 |
GO:0001658 | branching involved in ureteric bud morphogenesis | 7.054151e-4 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 7.200606e-4 |
GO:0010216 | maintenance of DNA methylation | 7.235063e-4 |
GO:0008361 | regulation of cell size | 7.368156e-4 |
GO:0021592 | fourth ventricle development | 7.405153e-4 |
GO:0060047 | heart contraction | 7.484004e-4 |
GO:0043547 | positive regulation of GTPase activity | 7.498640e-4 |
GO:0045773 | positive regulation of axon extension | 7.714129e-4 |
GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process | 7.842492e-4 |
GO:0001657 | ureteric bud development | 8.205977e-4 |
GO:0072210 | metanephric nephron development | 8.223206e-4 |
GO:0032965 | regulation of collagen biosynthetic process | 8.348679e-4 |
GO:0035307 | positive regulation of protein dephosphorylation | 8.722946e-4 |
GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining | 8.816435e-4 |
GO:2001038 | regulation of cellular response to drug | 8.816435e-4 |
GO:2000685 | positive regulation of cellular response to X-ray | 8.816435e-4 |
GO:0035978 | histone H2A-S139 phosphorylation | 8.816435e-4 |
GO:0003131 | mesodermal-endodermal cell signaling | 8.816435e-4 |
GO:0031052 | chromosome breakage | 8.816435e-4 |
GO:0035988 | chondrocyte proliferation | 8.816435e-4 |
GO:0022601 | menstrual cycle phase | 8.962976e-4 |
GO:0002009 | morphogenesis of an epithelium | 9.181841e-4 |
GO:0045660 | positive regulation of neutrophil differentiation | 9.454832e-4 |
GO:0033504 | floor plate development | 9.454832e-4 |
GO:0000432 | positive regulation of transcription from RNA polymerase II promoter by glucose | 9.454832e-4 |
GO:0071340 | skeletal muscle nicotinic acetylcholine receptor clustering | 9.877842e-4 |
GO:0046108 | uridine metabolic process | 9.877842e-4 |
GO:0072513 | positive regulation of secondary heart field cardioblast proliferation | 9.915204e-4 |
GO:0043555 | regulation of translation in response to stress | 9.915204e-4 |
GO:0035306 | positive regulation of dephosphorylation | 1.026104e-3 |
GO:0032353 | negative regulation of hormone biosynthetic process | 1.055798e-3 |
GO:0019441 | tryptophan catabolic process to kynurenine | 1.059919e-3 |
GO:0033365 | protein localization to organelle | 1.075618e-3 |
GO:0003158 | endothelium development | 1.102818e-3 |
GO:0051725 | protein de-ADP-ribosylation | 1.105437e-3 |
GO:0006713 | glucocorticoid catabolic process | 1.105437e-3 |
GO:0034227 | tRNA thio-modification | 1.141202e-3 |
GO:0014745 | negative regulation of muscle adaptation | 1.141202e-3 |
GO:0051188 | cofactor biosynthetic process | 1.168464e-3 |
GO:0051915 | induction of synaptic plasticity by chemical substance | 1.181254e-3 |
GO:0061046 | regulation of branching involved in lung morphogenesis | 1.184488e-3 |
GO:0060421 | positive regulation of heart growth | 1.184488e-3 |
GO:0090184 | positive regulation of kidney development | 1.187478e-3 |
GO:0045686 | negative regulation of glial cell differentiation | 1.237310e-3 |
GO:0061370 | testosterone biosynthetic process | 1.240767e-3 |
GO:0035928 | rRNA import into mitochondrion | 1.240767e-3 |
GO:0006685 | sphingomyelin catabolic process | 1.240767e-3 |
GO:0021904 | dorsal/ventral neural tube patterning | 1.251026e-3 |
GO:0021591 | ventricular system development | 1.289288e-3 |
GO:0016458 | gene silencing | 1.304264e-3 |
GO:0007354 | zygotic determination of anterior/posterior axis, embryo | 1.308684e-3 |
GO:0048880 | sensory system development | 1.308684e-3 |
GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 1.315787e-3 |
GO:0003157 | endocardium development | 1.327949e-3 |
GO:0003156 | regulation of organ formation | 1.380999e-3 |
GO:0072161 | mesenchymal cell differentiation involved in kidney development | 1.408949e-3 |
GO:0034380 | high-density lipoprotein particle assembly | 1.475207e-3 |
GO:0044253 | positive regulation of multicellular organismal metabolic process | 1.479452e-3 |
GO:0035195 | gene silencing by miRNA | 1.479452e-3 |
GO:0072088 | nephron epithelium morphogenesis | 1.516705e-3 |
GO:0090140 | regulation of mitochondrial fission | 1.522601e-3 |
GO:0046092 | deoxycytidine metabolic process | 1.522601e-3 |
GO:0060684 | epithelial-mesenchymal cell signaling | 1.557311e-3 |
GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation | 1.622869e-3 |
GO:0006361 | transcription initiation from RNA polymerase I promoter | 1.622869e-3 |
GO:0035850 | epithelial cell differentiation involved in kidney development | 1.649198e-3 |
GO:0014812 | muscle cell migration | 1.686342e-3 |
GO:0032776 | DNA methylation on cytosine | 1.707150e-3 |
GO:0021798 | forebrain dorsal/ventral pattern formation | 1.711878e-3 |
GO:0090196 | regulation of chemokine secretion | 1.742390e-3 |
GO:0065005 | protein-lipid complex assembly | 1.743047e-3 |
GO:0010807 | regulation of synaptic vesicle priming | 1.779974e-3 |
GO:0035865 | cellular response to potassium ion | 1.779974e-3 |
GO:0035494 | SNARE complex disassembly | 1.779974e-3 |
GO:0034651 | cortisol biosynthetic process | 1.779974e-3 |
GO:0014853 | regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction | 1.779974e-3 |
GO:0014003 | oligodendrocyte development | 1.798052e-3 |
GO:0007041 | lysosomal transport | 1.815094e-3 |
GO:0072109 | glomerular mesangium development | 1.846731e-3 |
GO:0048702 | embryonic neurocranium morphogenesis | 1.846731e-3 |
GO:0006657 | CDP-choline pathway | 1.874836e-3 |
GO:0015812 | gamma-aminobutyric acid transport | 1.876626e-3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 1.877412e-3 |
GO:0000729 | DNA double-strand break processing | 1.877412e-3 |
GO:0021520 | spinal cord motor neuron cell fate specification | 1.902211e-3 |
GO:0000028 | ribosomal small subunit assembly | 1.993664e-3 |
GO:0060562 | epithelial tube morphogenesis | 1.994968e-3 |
GO:0070189 | kynurenine metabolic process | 2.053786e-3 |
GO:0032057 | negative regulation of translational initiation in response to stress | 2.059354e-3 |
GO:0032342 | aldosterone biosynthetic process | 2.059354e-3 |
GO:0007288 | sperm axoneme assembly | 2.104843e-3 |
GO:0006398 | histone mRNA 3'-end processing | 2.118263e-3 |
GO:0072184 | renal vesicle progenitor cell differentiation | 2.129134e-3 |
GO:0072208 | metanephric smooth muscle tissue development | 2.129134e-3 |
GO:0072259 | metanephric interstitial cell development | 2.129134e-3 |
GO:0090094 | metanephric cap mesenchymal cell proliferation involved in metanephros development | 2.129134e-3 |
GO:0072169 | specification of posterior mesonephric tubule identity | 2.129134e-3 |
GO:0003273 | cell migration involved in endocardial cushion formation | 2.129134e-3 |
GO:0070179 | D-serine biosynthetic process | 2.129134e-3 |
GO:0072168 | specification of anterior mesonephric tubule identity | 2.129134e-3 |
GO:0072197 | ureter morphogenesis | 2.165209e-3 |
GO:0034379 | very-low-density lipoprotein particle assembly | 2.202376e-3 |
GO:0016322 | neuron remodeling | 2.243654e-3 |
GO:0002115 | store-operated calcium entry | 2.259847e-3 |
GO:0048663 | neuron fate commitment | 2.319178e-3 |
GO:0001578 | microtubule bundle formation | 2.320149e-3 |
GO:0046499 | S-adenosylmethioninamine metabolic process | 2.321664e-3 |
GO:0021993 | initiation of neural tube closure | 2.321664e-3 |
GO:0060390 | regulation of SMAD protein import into nucleus | 2.352863e-3 |
GO:0042255 | ribosome assembly | 2.352863e-3 |
GO:0061014 | positive regulation of mRNA catabolic process | 2.434470e-3 |
GO:0032967 | positive regulation of collagen biosynthetic process | 2.452445e-3 |
GO:0090179 | planar cell polarity pathway involved in neural tube closure | 2.471127e-3 |
GO:0016072 | rRNA metabolic process | 2.519196e-3 |
GO:0032330 | regulation of chondrocyte differentiation | 2.550400e-3 |
GO:0045685 | regulation of glial cell differentiation | 2.563807e-3 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 2.601883e-3 |
GO:0021872 | forebrain generation of neurons | 2.681230e-3 |
GO:0072079 | nephron tubule formation | 2.685432e-3 |
GO:0043087 | regulation of GTPase activity | 2.690246e-3 |
GO:0042921 | glucocorticoid receptor signaling pathway | 2.730795e-3 |
GO:0003229 | ventricular cardiac muscle tissue development | 2.803905e-3 |
GO:0014014 | negative regulation of gliogenesis | 2.921907e-3 |
GO:0045415 | negative regulation of interleukin-8 biosynthetic process | 2.942213e-3 |
GO:0002642 | positive regulation of immunoglobulin biosynthetic process | 2.942213e-3 |
GO:0033124 | regulation of GTP catabolic process | 2.962947e-3 |
GO:0048747 | muscle fiber development | 2.964841e-3 |
GO:0072104 | glomerular capillary formation | 2.965254e-3 |
GO:0051299 | centrosome separation | 2.981449e-3 |
GO:0072384 | organelle transport along microtubule | 3.004437e-3 |
GO:0061138 | morphogenesis of a branching epithelium | 3.025441e-3 |
GO:0071799 | cellular response to prostaglandin D stimulus | 3.033475e-3 |
GO:0071105 | response to interleukin-11 | 3.033475e-3 |
GO:0070535 | histone H2A K63-linked ubiquitination | 3.033475e-3 |
GO:0018872 | arsonoacetate metabolic process | 3.033475e-3 |
GO:0050883 | musculoskeletal movement, spinal reflex action | 3.099506e-3 |
GO:0045738 | negative regulation of DNA repair | 3.099506e-3 |
GO:0050711 | negative regulation of interleukin-1 secretion | 3.103635e-3 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 3.237842e-3 |
GO:0007595 | lactation | 3.270771e-3 |
GO:0043010 | camera-type eye development | 3.328140e-3 |
GO:0072091 | regulation of stem cell proliferation | 3.366543e-3 |
GO:0007522 | visceral muscle development | 3.366543e-3 |
GO:0048638 | regulation of developmental growth | 3.370023e-3 |
GO:2000679 | positive regulation of transcription regulatory region DNA binding | 3.385684e-3 |
GO:0006412 | translation | 3.426257e-3 |
GO:0032331 | negative regulation of chondrocyte differentiation | 3.512800e-3 |
GO:0032472 | Golgi calcium ion transport | 3.543087e-3 |
GO:0032468 | Golgi calcium ion homeostasis | 3.543087e-3 |
GO:0008208 | C21-steroid hormone catabolic process | 3.543087e-3 |
GO:0030026 | cellular manganese ion homeostasis | 3.543087e-3 |
GO:0042727 | flavin-containing compound biosynthetic process | 3.556308e-3 |
GO:0014056 | regulation of acetylcholine secretion | 3.761575e-3 |
GO:0070498 | interleukin-1-mediated signaling pathway | 3.769614e-3 |
GO:0008654 | phospholipid biosynthetic process | 3.774584e-3 |
GO:0070534 | protein K63-linked ubiquitination | 3.872153e-3 |
GO:0006568 | tryptophan metabolic process | 3.889019e-3 |
GO:0034142 | toll-like receptor 4 signaling pathway | 3.927298e-3 |
GO:0002268 | follicular dendritic cell differentiation | 3.941833e-3 |
GO:0045995 | regulation of embryonic development | 3.997352e-3 |
GO:0016075 | rRNA catabolic process | 4.076725e-3 |
GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis | 4.106043e-3 |
GO:0009637 | response to blue light | 4.109744e-3 |
GO:0045662 | negative regulation of myoblast differentiation | 4.134667e-3 |
GO:0010936 | negative regulation of macrophage cytokine production | 4.142135e-3 |
GO:0021750 | vestibular nucleus development | 4.142135e-3 |
GO:0042696 | menarche | 4.142135e-3 |
GO:0021590 | cerebellum maturation | 4.142135e-3 |
GO:0021679 | cerebellar molecular layer development | 4.142135e-3 |
GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis | 4.184154e-3 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 4.196759e-3 |
GO:0071279 | cellular response to cobalt ion | 4.291536e-3 |
GO:0046724 | oxalic acid secretion | 4.291536e-3 |
GO:0000244 | assembly of spliceosomal tri-snRNP | 4.291536e-3 |
GO:0010637 | negative regulation of mitochondrial fusion | 4.291536e-3 |
GO:0019265 | glycine biosynthetic process, by transamination of glyoxylate | 4.291536e-3 |
GO:0001885 | endothelial cell development | 4.316085e-3 |
GO:0072009 | nephron epithelium development | 4.359539e-3 |
GO:0060449 | bud elongation involved in lung branching | 4.449619e-3 |
GO:0090141 | positive regulation of mitochondrial fission | 4.547305e-3 |
GO:0072183 | negative regulation of nephron tubule epithelial cell differentiation | 4.547305e-3 |
GO:0071460 | cellular response to cell-matrix adhesion | 4.547305e-3 |
GO:0051865 | protein autoubiquitination | 4.580951e-3 |
GO:0060644 | mammary gland epithelial cell differentiation | 4.641260e-3 |
GO:0035194 | posttranscriptional gene silencing by RNA | 4.678465e-3 |
GO:0003163 | sinoatrial node development | 4.683999e-3 |
GO:0060441 | epithelial tube branching involved in lung morphogenesis | 4.691774e-3 |
GO:0033599 | regulation of mammary gland epithelial cell proliferation | 4.694694e-3 |
GO:0035282 | segmentation | 4.788921e-3 |
GO:0007034 | vacuolar transport | 4.863299e-3 |
GO:0033135 | regulation of peptidyl-serine phosphorylation | 4.949825e-3 |
GO:2000648 | positive regulation of stem cell proliferation | 4.996112e-3 |
GO:0060914 | heart formation | 4.996112e-3 |
GO:0034446 | substrate adhesion-dependent cell spreading | 5.020498e-3 |
GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation | 5.095798e-3 |
GO:2000020 | positive regulation of male gonad development | 5.113590e-3 |
GO:0050772 | positive regulation of axonogenesis | 5.120320e-3 |
GO:0007398 | ectoderm development | 5.128847e-3 |
GO:0003338 | metanephros morphogenesis | 5.138486e-3 |
GO:0045444 | fat cell differentiation | 5.154117e-3 |
GO:0014040 | positive regulation of Schwann cell differentiation | 5.159374e-3 |
GO:0009992 | cellular water homeostasis | 5.159374e-3 |
GO:0008054 | cyclin catabolic process | 5.189349e-3 |
GO:0048665 | neuron fate specification | 5.196228e-3 |
GO:0031440 | regulation of mRNA 3'-end processing | 5.199835e-3 |
GO:0010771 | negative regulation of cell morphogenesis involved in differentiation | 5.228719e-3 |
GO:0060122 | inner ear receptor stereocilium organization | 5.242116e-3 |
GO:0023021 | termination of signal transduction | 5.288055e-3 |
GO:0003139 | secondary heart field specification | 5.369046e-3 |
GO:0060913 | cardiac cell fate determination | 5.463511e-3 |
GO:0006363 | termination of RNA polymerase I transcription | 5.463511e-3 |
GO:0072273 | metanephric nephron morphogenesis | 5.507484e-3 |
GO:0032530 | regulation of microvillus organization | 5.543671e-3 |
GO:0010107 | potassium ion import | 5.543671e-3 |
GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning | 5.717751e-3 |
GO:0006437 | tyrosyl-tRNA aminoacylation | 5.717751e-3 |
GO:0032488 | Cdc42 protein signal transduction | 5.786416e-3 |
GO:2000018 | regulation of male gonad development | 5.786416e-3 |
GO:0033137 | negative regulation of peptidyl-serine phosphorylation | 5.852336e-3 |
GO:0009948 | anterior/posterior axis specification | 5.869617e-3 |
GO:0002064 | epithelial cell development | 5.926526e-3 |
GO:0006290 | pyrimidine dimer repair | 5.952499e-3 |
GO:0033363 | secretory granule organization | 6.004218e-3 |
GO:0031929 | TOR signaling cascade | 6.066155e-3 |
GO:0006493 | protein O-linked glycosylation | 6.101501e-3 |
GO:0030513 | positive regulation of BMP signaling pathway | 6.178185e-3 |
GO:0070672 | response to interleukin-15 | 6.228350e-3 |
GO:0045764 | positive regulation of cellular amino acid metabolic process | 6.228350e-3 |
GO:0035089 | establishment of apical/basal cell polarity | 6.235546e-3 |
GO:0003407 | neural retina development | 6.407622e-3 |
GO:2000352 | negative regulation of endothelial cell apoptosis | 6.481277e-3 |
GO:0071353 | cellular response to interleukin-4 | 6.531427e-3 |
GO:0048676 | axon extension involved in development | 6.561514e-3 |
GO:0014842 | regulation of satellite cell proliferation | 6.747089e-3 |
GO:0060993 | kidney morphogenesis | 6.769040e-3 |
GO:0035511 | oxidative DNA demethylation | 6.770850e-3 |
GO:0003015 | heart process | 6.784267e-3 |
GO:0030049 | muscle filament sliding | 6.799350e-3 |
GO:0072078 | nephron tubule morphogenesis | 6.813270e-3 |
GO:0016049 | cell growth | 6.931677e-3 |
GO:0018158 | protein oxidation | 6.976460e-3 |
GO:0061005 | cell differentiation involved in kidney development | 7.025327e-3 |
GO:0021759 | globus pallidus development | 7.109577e-3 |
GO:0090303 | positive regulation of wound healing | 7.109577e-3 |
GO:0009651 | response to salt stress | 7.263805e-3 |
GO:0010834 | telomere maintenance via telomere shortening | 7.269207e-3 |
GO:0001300 | chronological cell aging | 7.269207e-3 |
GO:0032691 | negative regulation of interleukin-1 beta production | 7.325877e-3 |
GO:0000738 | DNA catabolic process, exonucleolytic | 7.380188e-3 |
GO:0042256 | mature ribosome assembly | 7.431304e-3 |
GO:0070328 | triglyceride homeostasis | 7.477383e-3 |
GO:0009894 | regulation of catabolic process | 7.648707e-3 |
GO:0021895 | cerebral cortex neuron differentiation | 7.674242e-3 |
GO:0006338 | chromatin remodeling | 7.727103e-3 |
GO:0046604 | positive regulation of mitotic centrosome separation | 7.924835e-3 |
GO:0071638 | negative regulation of monocyte chemotactic protein-1 production | 7.924835e-3 |
GO:2000469 | negative regulation of peroxidase activity | 7.924835e-3 |
GO:0035726 | common myeloid progenitor cell proliferation | 7.924835e-3 |
GO:2000429 | negative regulation of neutrophil aggregation | 7.924835e-3 |
GO:0021528 | commissural neuron differentiation in spinal cord | 7.924835e-3 |
GO:0002561 | basophil degranulation | 7.924835e-3 |
GO:0032532 | regulation of microvillus length | 7.924835e-3 |
GO:0021941 | negative regulation of cerebellar granule cell precursor proliferation | 7.924835e-3 |
GO:0031053 | primary miRNA processing | 7.924835e-3 |
GO:0030854 | positive regulation of granulocyte differentiation | 7.962026e-3 |
GO:0010760 | negative regulation of macrophage chemotaxis | 8.012195e-3 |
GO:0048706 | embryonic skeletal system development | 8.091387e-3 |
GO:0030856 | regulation of epithelial cell differentiation | 8.142913e-3 |
GO:0019363 | pyridine nucleotide biosynthetic process | 8.163093e-3 |
GO:0006824 | cobalt ion transport | 8.165718e-3 |
GO:0022010 | central nervous system myelination | 8.218375e-3 |
GO:0014013 | regulation of gliogenesis | 8.227840e-3 |
GO:0070584 | mitochondrion morphogenesis | 8.290442e-3 |
GO:0034661 | ncRNA catabolic process | 8.408204e-3 |
GO:0009069 | serine family amino acid metabolic process | 8.415169e-3 |
GO:0072087 | renal vesicle development | 8.446865e-3 |
GO:0021578 | hindbrain maturation | 8.564713e-3 |
GO:0060119 | inner ear receptor cell development | 8.665010e-3 |
GO:0035633 | maintenance of blood-brain barrier | 8.753314e-3 |
GO:0021513 | spinal cord dorsal/ventral patterning | 8.763004e-3 |
GO:0010608 | posttranscriptional regulation of gene expression | 8.994096e-3 |
GO:0042402 | cellular biogenic amine catabolic process | 9.013987e-3 |
GO:0060850 | regulation of transcription involved in cell fate commitment | 9.078274e-3 |
GO:0061013 | regulation of mRNA catabolic process | 9.107881e-3 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 9.114613e-3 |
GO:2000826 | regulation of heart morphogenesis | 9.352726e-3 |
GO:0030516 | regulation of axon extension | 9.432446e-3 |